Trials / Completed
CompletedNCT00000353
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 19 Years – 57 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone |
Timeline
- Start date
- 1996-10-01
- Primary completion
- 1997-09-01
- Completion
- 1997-10-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000353. Inclusion in this directory is not an endorsement.